Cargando…

Metabolic Profiling of Rheumatoid Arthritis Neutrophils Reveals Altered Energy Metabolism That Is Not Affected by JAK Inhibition

Neutrophils play a key role in the pathophysiology of rheumatoid arthritis (RA) where release of ROS and proteases directly causes damage to joints and tissues. Neutrophil function can be modulated by Janus Kinase (JAK) inhibitor drugs, including tofacitinib and baricitinib, which are clinically eff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chokesuwattanaskul, Susama, Fresneda Alarcon, Michele, Mangalakumaran, Sangeetha, Grosman, Rudi, Cross, Andrew L., Chapman, Elinor A., Mason, David, Moots, Robert J., Phelan, Marie M., Wright, Helen L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321732/ https://www.ncbi.nlm.nih.gov/pubmed/35888774 http://dx.doi.org/10.3390/metabo12070650

Ejemplares similares

A robust intracellular metabolite extraction protocol for human neutrophil metabolic profiling
por: Chokesuwattanaskul, Susama, et al.
Publicado: (2018)

Rheumatoid Arthritis Synovial Fluid Neutrophils Drive Inflammation Through Production of Chemokines, Reactive Oxygen Species, and Neutrophil Extracellular Traps
por: Wright, Helen L., et al.
Publicado: (2021)

Caught in a Trap? Proteomic Analysis of Neutrophil Extracellular Traps in Rheumatoid Arthritis and Systemic Lupus Erythematosus
por: Chapman, Elinor A., et al.
Publicado: (2019)

(1)H NMR Metabolomics Identifies Underlying Inflammatory Pathology in Osteoarthritis and Rheumatoid Arthritis Synovial Joints
por: Anderson, James R., et al.
Publicado: (2018)

Neutrophils in the Pathogenesis of Rheumatoid Arthritis and Systemic Lupus Erythematosus: Same Foe Different M.O.
por: Fresneda Alarcon, Michele, et al.
Publicado: (2021)

Low-dose Amiodarone Is Safe: A Systematic Review and Meta-analysis
por: Chokesuwattanaskul, Ronpichai, et al.
Publicado: (2020)

Ferroptosis: A Potential Therapeutic Target in Acute Kidney Injury
por: Hosohata, Keiko, et al.
Publicado: (2022)

APPA (apocynin and paeonol) modulates pathological aspects of human neutrophil function, without supressing antimicrobial ability, and inhibits TNFα expression and signalling
por: Cross, A. L., et al.
Publicado: (2020)

Globe rupture: a single-center retrospective study of demographic patterns and outcomes
por: Choovuthayakorn, Janejit, et al.
Publicado: (2020)

Internalization of Neutrophil-Derived Microvesicles Modulates TNFα-Stimulated Proinflammatory Cytokine Production in Human Fibroblast-Like Synoviocytes
por: Zhan, Dong, et al.
Publicado: (2021)

The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis
por: Boyle, D L, et al.
Publicado: (2015)

JAK-STAT and bone metabolism
por: Li, Jiliang
Publicado: (2013)

Biomarkers for Treatment Response in Rheumatoid Arthritis: Where are they?
por: Zhao, Sizheng Steven, et al.
Publicado: (2020)

Targeting nanomedicines in the treatment of rheumatoid arthritis: focus on certolizumab pegol
por: Barnes, Theresa, et al.
Publicado: (2007)

Whose Gene Is It Anyway? The Effect of Preparation Purity on Neutrophil Transcriptome Studies
por: Thomas, Huw B., et al.
Publicado: (2015)

Metabolic Syndrome in Rheumatoid Arthritis
por: Ferraz-Amaro, Iván, et al.
Publicado: (2013)

Metabolic Checkpoints in Rheumatoid Arthritis
por: Pucino, Valentina, et al.
Publicado: (2020)

Lipid metabolism and rheumatoid arthritis
por: Lei, Qian, et al.
Publicado: (2023)

Clinical efficacy of launched JAK inhibitors in rheumatoid arthritis
por: Taylor, Peter C
Publicado: (2019)

Pain in Rheumatoid Arthritis: Could JAK Inhibition be the Answer?
por: Mehta, Puja, et al.
Publicado: (2020)

JAK/STAT pathway in pathology of rheumatoid arthritis (Review)
por: Ciobanu, Dana Alexandra, et al.
Publicado: (2020)

Clinical use of Jak 1 inhibitors for rheumatoid arthritis
por: Nash, Peter
Publicado: (2021)

Type I interferon regulates cytokine‐delayed neutrophil apoptosis, reactive oxygen species production and chemokine expression
por: Glennon‐Alty, L., et al.
Publicado: (2020)

Review of Biosimilar Trials and Data on Adalimumab in Rheumatoid Arthritis
por: Zhao, Sizheng, et al.
Publicado: (2018)

Review of Biosimilar Trials and Data on Etanercept in Rheumatoid Arthritis
por: Chadwick, Laura, et al.
Publicado: (2018)

RNA-Seq Reveals Activation of Both Common and Cytokine-Specific Pathways following Neutrophil Priming
por: Wright, Helen L., et al.
Publicado: (2013)

JAK-STAT signaling and myocardial glucose metabolism
por: Frias, Miguel A, et al.
Publicado: (2013)

Growing evidence of the safety of JAK inhibitors in patients with rheumatoid arthritis
por: Harigai, Masayoshi
Publicado: (2019)

Negative Regulators of JAK/STAT Signaling in Rheumatoid Arthritis and Osteoarthritis
por: Malemud, Charles J.
Publicado: (2017)

A JAK Inhibitor for Treatment of Rheumatoid Arthritis: The Baricitinib Experience
por: Taylor, Peter C., et al.
Publicado: (2023)

Abnormal Glucose Metabolism in Rheumatoid Arthritis
por: Pi, Hui, et al.
Publicado: (2017)

Visual acuity and anatomical changes following vitrectomy for epiretinal membrane foveoschisis: a case series
por: Photcharapongsakul, Chaiyaphot, et al.
Publicado: (2021)

Prevalence of symptomatic dry eye disease with associated risk factors among medical students at Chiang Mai University due to increased screen time and stress during COVID-19 pandemic
por: Tangmonkongvoragul, Chulaluck, et al.
Publicado: (2022)

Effect of tocilizumab on neutrophils in adult patients with rheumatoid arthritis: pooled analysis of data from phase 3 and 4 clinical trials
por: Moots, Robert J., et al.
Publicado: (2017)

Skeletal muscle dysregulation in rheumatoid arthritis: Metabolic and molecular markers in a rodent model and patients
por: Casanova-Vallve, Nuria, et al.
Publicado: (2020)

Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis
por: Meyer, Debra M, et al.
Publicado: (2010)

Clinical utility of the oral JAK inhibitor tofacitinib in the treatment of rheumatoid arthritis
por: Cutolo, Maurizio, et al.
Publicado: (2013)

JAK Inhibitors and Modulation of B Cell Immune Responses in Rheumatoid Arthritis
por: Moura, Rita A., et al.
Publicado: (2021)

Phase III trials of JAK1 selective inhibitors in rheumatoid arthritis
por: Mysler, Eduardo, et al.
Publicado: (2021)

Early phase studies of JAK1 selective inhibitors in rheumatoid arthritis
por: Avci, Ali Berkant, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tagi225uv269kbrffeulejqrgu